Published in Birth Defects Res A Clin Mol Teratol on October 25, 2012
Adjusting for bias due to incomplete case ascertainment in case-control studies of birth defects. Am J Epidemiol (2015) 0.78
A description of spina bifida cases and co-occurring malformations, 1976-2011. Am J Med Genet A (2013) 0.76
Ascertaining the Burden of Birth Defects. Am J Prev Med (2016) 0.75
Myoinositol: The Bridge (PONTI) to Reach a Healthy Pregnancy. Int J Endocrinol (2017) 0.75
Pregnancy continuation and organizational religious activity following prenatal diagnosis of a lethal fetal defect are associated with improved psychological outcome. Prenat Diagn (2015) 0.75
Prenatal diagnosis and assessment of congenital spinal anomalies: Review for prenatal counseling. World J Orthop (2016) 0.75
Measuring inconsistency in meta-analyses. BMJ (2003) 128.20
Neural-tube defects. N Engl J Med (1999) 5.47
Effect of maternal obesity on the ultrasound detection of anomalous fetuses. Obstet Gynecol (2009) 2.20
Prenatal diagnosis of severe structural congenital malformations in Europe. Ultrasound Obstet Gynecol (2005) 2.19
Spina bifida. Lancet (2004) 2.02
Trends in congenital malformations, 1974-1999: effect of prenatal diagnosis and elective termination. Obstet Gynecol (2004) 1.92
Survival of infants with neural tube defects in the presence of folic acid fortification. Pediatrics (2006) 1.72
Including prenatal diagnoses in birth defects monitoring: Experience of the Metropolitan Atlanta Congenital Defects Program. Birth Defects Res A Clin Mol Teratol (2009) 1.33
Variation in the decision to terminate pregnancy in the setting of fetal aneuploidy. Prenat Diagn (2006) 1.18
Impact of maternal obesity on procedure of mid-trimester anomaly scan. J Obstet Gynaecol (2010) 1.10
Impact of prenatal diagnosis and elective termination on prevalence and risk estimates of neural tube defects in California, 1989-1991. Am J Epidemiol (1996) 1.05
Prenatal screening and diagnosis of neural tube defects. Prenat Diagn (2009) 0.99
Screening for fetal aneuploidy and neural tube defects. Genet Med (2009) 0.98
Surveillance for anencephaly and spina bifida and the impact of prenatal diagnosis--United States, 1985-1994. MMWR CDC Surveill Summ (1995) 0.97
Impact of prenatal diagnosis on the birth prevalence of neural tube defects, Atlanta, 1990-1991. Pediatrics (1995) 0.97
The impact of maternal obesity on midtrimester sonographic visualization of fetal cardiac and craniospinal structures. Int J Obes Relat Metab Disord (2004) 0.96
Effect of prenatal diagnosis on epidemiologic studies of birth defects. Epidemiology (2000) 0.95
Parental decisions to terminate/continue following abnormal cytogenetic prenatal diagnosis: "what" is still more important than "when". Am J Med Genet (1996) 0.92
Spontaneous pregnancy outcome after prenatal diagnosis of anencephaly. BJOG (2006) 0.90
Neural tube defects in Switzerland from 2001 to 2007: are periconceptual folic acid recommendations being followed? Swiss Med Wkly (2008) 0.89
The incidence of spina bifida in Sweden 1973-2003: the effect of prenatal diagnosis. Eur J Public Health (2006) 0.89
The natural history of anencephaly. Prenat Diagn (2010) 0.87
Interpreting changes in the epidemiology of anencephaly and spina bifida following folic acid fortification of the U.S. grain supply in the setting of long-term trends, Atlanta, Georgia, 1968-2003. Birth Defects Res A Clin Mol Teratol (2007) 0.86
Prenatal diagnosis and elective termination of neural tube defects in Hawaii, 1986-1997. Fetal Diagn Ther (2000) 0.85
Prognosis of spina bifida in the era of prenatal diagnosis and termination of pregnancy. Fetal Diagn Ther (2009) 0.85
Comparison of six sonographic signs in the prenatal diagnosis of spina bifida. J Perinat Med (2008) 0.84
Prenatal ultrasound detection of isolated neural tube defects: is cytogenetic evaluation warranted? Obstet Gynecol (1995) 0.83
Validity of death and stillbirth certificates and hospital discharge summaries for the identification of neural tube defects in Quebec City. Chronic Dis Can (2006) 0.83
Frequency of prenatal diagnosis of birth defects in Houston, Galveston and the Lower Rio Grande Valley, Texas 1995. Fetal Diagn Ther (2001) 0.82
Fetal open spina bifida: a natural history of disease progression in utero. Prenat Diagn (2004) 0.80
Ascertainment of pregnancies terminated because of birth defects: effect on completeness of adding a new source of data. Teratology (2001) 0.80
Anencephaly: do the pregnancy and maternal characteristics impact the pregnancy outcome? ISRN Obstet Gynecol (2012) 0.79
Importance of including all pregnancy outcomes to reduce bias in epidemiologic studies of neural tube defects--Texas, 1999 to 2005. Birth Defects Res A Clin Mol Teratol (2011) 0.79
Family planning decisions after prenatal detection of fetal abnormalities. Am J Obstet Gynecol (1994) 0.78
Audit of prenatal and postnatal diagnosis of isolated open spina bifida in three university hospitals in The Netherlands. Ultrasound Obstet Gynecol (2003) 0.78
Prenatal diagnosis of open and closed spina bifida. Ultrasound Obstet Gynecol (2006) 0.77
Pediatric perspective on prenatal counseling for myelomeningocele. Birth Defects Res A Clin Mol Teratol (2006) 0.77
Investigation of ultrasound screening efficiency for neural tube defects during pregnancy in rural areas of China. Public Health (2011) 0.77
Outcome of children with prenatally diagnosed central nervous system malformations. Ultrasound Obstet Gynecol (2003) 0.77
Bio-monitoring the elimination of folic acid-preventable spina bifida and anencephaly. Reprod Toxicol (2008) 0.77
Prenatal course and outcome in 103 cases of fetal spina bifida: a single center experience. Acta Obstet Gynecol Scand (2010) 0.76
H1N1 2009 influenza virus infection during pregnancy in the USA. Lancet (2009) 12.32
Pandemic 2009 influenza A(H1N1) virus illness among pregnant women in the United States. JAMA (2010) 5.94
Severe 2009 H1N1 influenza in pregnant and postpartum women in California. N Engl J Med (2009) 5.35
Decline in the prevalence of spina bifida and anencephaly by race/ethnicity: 1995-2002. Pediatrics (2005) 4.91
Maternal treatment with opioid analgesics and risk for birth defects. Am J Obstet Gynecol (2011) 4.14
National estimates and race/ethnic-specific variation of selected birth defects in the United States, 1999-2001. Birth Defects Res A Clin Mol Teratol (2006) 4.08
Use of selective serotonin-reuptake inhibitors in pregnancy and the risk of birth defects. N Engl J Med (2007) 3.79
Risk of bacterial meningitis in children with cochlear implants. N Engl J Med (2003) 3.75
Use of over-the-counter medications during pregnancy. Am J Obstet Gynecol (2005) 3.37
Mortality associated with Down's syndrome in the USA from 1983 to 1997: a population-based study. Lancet (2002) 3.35
BioCycle study: design of the longitudinal study of the oxidative stress and hormone variation during the menstrual cycle. Paediatr Perinat Epidemiol (2009) 3.07
The contribution of preterm birth to infant mortality rates in the United States. Pediatrics (2006) 3.01
A population-based study of the 22q11.2 deletion: phenotype, incidence, and contribution to major birth defects in the population. Pediatrics (2003) 2.88
Emerging infections and pregnancy. Emerg Infect Dis (2006) 2.75
Severity of 2009 pandemic influenza A (H1N1) virus infection in pregnant women. Obstet Gynecol (2010) 2.69
Birth outcomes following West Nile Virus infection of pregnant women in the United States: 2003-2004. Pediatrics (2006) 2.53
Prepregnancy obesity as a risk factor for structural birth defects. Arch Pediatr Adolesc Med (2007) 2.43
Maternal obesity and risk for birth defects. Pediatrics (2003) 2.33
What obstetrician-gynecologists should know about Ebola: a perspective from the Centers for Disease Control and Prevention. Obstet Gynecol (2014) 2.04
Sharing prescription medication among teenage girls: potential danger to unplanned/undiagnosed pregnancies. Pediatrics (2003) 1.99
Maternal nutrient intakes and risk of orofacial clefts. Epidemiology (2006) 1.70
Health care expenditures for infants and young children with Down syndrome in a privately insured population. J Pediatr (2008) 1.70
2009 pandemic influenza A (H1N1) in pregnancy: a systematic review of the literature. Am J Obstet Gynecol (2011) 1.69
Effect of daily fiber intake on reproductive function: the BioCycle Study. Am J Clin Nutr (2009) 1.69
Association between pregnancy intention and reproductive-health related behaviors before and after pregnancy recognition, National Birth Defects Prevention Study, 1997-2002. Matern Child Health J (2009) 1.68
Maternal smoking and environmental tobacco smoke exposure and the risk of orofacial clefts. Epidemiology (2007) 1.67
Medications used to treat nausea and vomiting of pregnancy and the risk of selected birth defects. Birth Defects Res A Clin Mol Teratol (2011) 1.66
Prescription medication borrowing and sharing among women of reproductive age. J Womens Health (Larchmt) (2008) 1.64
A population-based study of craniosynostosis in metropolitan Atlanta, 1989-2003. Am J Med Genet A (2008) 1.63
Maternal age and non-chromosomal birth defects, Atlanta--1968-2000: teenager or thirty-something, who is at risk? Birth Defects Res A Clin Mol Teratol (2004) 1.63
Are children born after assisted reproductive technology at increased risk for adverse health outcomes? Obstet Gynecol (2004) 1.61
An epidemiologic assessment of genomic profiling for measuring susceptibility to common diseases and targeting interventions. Genet Med (2004) 1.57
Adverse event reports after tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccines in pregnant women. Am J Obstet Gynecol (2012) 1.56
Update: Interim Guidelines for Health Care Providers Caring for Pregnant Women and Women of Reproductive Age with Possible Zika Virus Exposure - United States, 2016. MMWR Morb Mortal Wkly Rep (2016) 1.56
Orofacial clefts in the National Birth Defects Prevention Study, 1997-2004. Am J Med Genet A (2009) 1.55
Recruitment for a community-based study of early pregnancy: the Right From The Start study. Paediatr Perinat Epidemiol (2004) 1.55
The Food and Drug Administration must require the addition of more folic acid in "enriched" flour and other grains. Pediatrics (2005) 1.55
Applying public health strategies to primary immunodeficiency diseases: a potential approach to genetic disorders. MMWR Recomm Rep (2004) 1.52
Maternal smoking and congenital heart defects. Pediatrics (2008) 1.49
Health concerns of women and infants in times of natural disasters: lessons learned from Hurricane Katrina. Matern Child Health J (2007) 1.48
Temporal trends in survival among infants with critical congenital heart defects. Pediatrics (2013) 1.45
Antidepressant Prescription Claims Among Reproductive-Aged Women With Private Employer-Sponsored Insurance - United States 2008-2013. MMWR Morb Mortal Wkly Rep (2016) 1.43
Study design options in evaluating gene-environment interactions: practical considerations for a planned case-control study of pediatric leukemia. Pediatr Blood Cancer (2007) 1.42
Association of biochemical B₁₂ deficiency with metformin therapy and vitamin B₁₂ supplements: the National Health and Nutrition Examination Survey, 1999-2006. Diabetes Care (2011) 1.41
Update: Interim Guidance for Health Care Providers Caring for Pregnant Women with Possible Zika Virus Exposure - United States, July 2016. MMWR Morb Mortal Wkly Rep (2016) 1.41
Chlamydia positivity trends among women attending family planning clinics: United States, 2004-2008. Sex Transm Dis (2011) 1.41
Potential sensitivity of bias analysis results to incorrect assumptions of nondifferential or differential binary exposure misclassification. Epidemiology (2014) 1.39
Association between prepregnancy body mass index and congenital heart defects. Am J Obstet Gynecol (2009) 1.38
Racial differences in infant mortality attributable to birth defects in the United States, 1989-2002. Birth Defects Res A Clin Mol Teratol (2006) 1.34
Maternal corticosteroid use and orofacial clefts. Am J Obstet Gynecol (2007) 1.34
Interim Guidelines for the Evaluation and Testing of Infants with Possible Congenital Zika Virus Infection - United States, 2016. MMWR Morb Mortal Wkly Rep (2016) 1.29
Patterns of antidepressant medication use among pregnant women in a United States population. J Clin Pharmacol (2010) 1.28
Medications in the first trimester of pregnancy: most common exposures and critical gaps in understanding fetal risk. Pharmacoepidemiol Drug Saf (2013) 1.25
The contribution of chromosomal abnormalities to congenital heart defects: a population-based study. Pediatr Cardiol (2011) 1.24
Spina bifida and anencephaly prevalence--United States, 1991-2001. MMWR Recomm Rep (2002) 1.22
Herbal use before and during pregnancy. Am J Obstet Gynecol (2009) 1.21
Update: Interim Guidance for Health Care Providers Caring for Women of Reproductive Age with Possible Zika Virus Exposure - United States, 2016. MMWR Morb Mortal Wkly Rep (2016) 1.21
Delaying folic acid fortification of flour. BMJ (2002) 1.19
Bayesian methods for correcting misclassification: an example from birth defects epidemiology. Epidemiology (2009) 1.19
Maternal attitudes toward DNA collection for gene-environment studies: a qualitative research study. Am J Med Genet A (2009) 1.18
Priorities for future public health research in orofacial clefts. Cleft Palate Craniofac J (2007) 1.18
Reviewing the evidence for mycophenolate mofetil as a new teratogen: case report and review of the literature. Am J Med Genet A (2009) 1.17
Children with orofacial clefts: health-care use and costs among a privately insured population. Public Health Rep (2009) 1.16
Selective serotonin-reuptake inhibitors and persistent pulmonary hypertension of the newborn. N Engl J Med (2006) 1.16
Birth weight, postnatal growth, and risk for high blood pressure at 7 years of age: results from the Collaborative Perinatal Project. Pediatrics (2007) 1.13
Correlates of seasonal influenza vaccine coverage among pregnant women in Georgia and Rhode Island. Obstet Gynecol (2010) 1.13
Maternal periconceptional alcohol consumption and risk of orofacial clefts. Am J Epidemiol (2007) 1.13
Prolonged Detection of Zika Virus RNA in Pregnant Women. Obstet Gynecol (2016) 1.12
Intent to become pregnant as a predictor of exposures during pregnancy: is there a relation? J Reprod Med (2005) 1.11
Lymphocytic choriomeningitis virus: an emerging obstetric pathogen? Am J Obstet Gynecol (2006) 1.11
Prophylaxis and treatment of pregnant women for emerging infections and bioterrorism emergencies. Emerg Infect Dis (2006) 1.11
Caffeine and miscarriage risk. Epidemiology (2008) 1.11
Medication use during pregnancy and lactation: an urgent call for public health action. J Womens Health (Larchmt) (2005) 1.10
Response to importation of a case of Ebola virus disease--Ohio, October 2014. MMWR Morb Mortal Wkly Rep (2014) 1.08
Zika Virus Infection Among U.S. Pregnant Travelers - August 2015-February 2016. MMWR Morb Mortal Wkly Rep (2016) 1.08
Pediatric inpatient hospital resource use for congenital heart defects. Birth Defects Res A Clin Mol Teratol (2014) 1.08
Public health science agenda for congenital heart defects: report from a Centers for Disease Control and Prevention experts meeting. J Am Heart Assoc (2013) 1.07
Racial and ethnic disparity in participation in DNA collection at the Atlanta site of the National Birth Defects Prevention Study. Am J Epidemiol (2006) 1.05
Is there epidemiologic evidence to support vascular disruption as a pathogenesis of gastroschisis? Am J Med Genet A (2009) 1.05
Obstetrician/gynecologists' knowledge, attitudes, and practices regarding prevention of infections in pregnancy. J Womens Health (Larchmt) (2009) 1.03
Prevalence of self-reported infection during pregnancy among control mothers in the National Birth Defects Prevention Study. Birth Defects Res A Clin Mol Teratol (2009) 1.02
Should folic acid fortification be mandatory? Yes. BMJ (2007) 1.02
Population-based study of congenital diaphragmatic hernia: risk factors and survival in Metropolitan Atlanta, 1968-1999. Birth Defects Res A Clin Mol Teratol (2003) 1.02
Maternal body mass index and lifestyle exposures and the risk of bilateral renal agenesis or hypoplasia: the National Birth Defects Prevention Study. Am J Epidemiol (2008) 1.01